Blog - Page 497 of 5639 - QualityStocks

WednesdayFeb 28, 2024 9:45 am

Venture Debt Market Rebounds as Deal Flows Surge

Early-stage lending fell 44% year-over-year in the first six months of 2023 following Silicon Valley Bank collapse Demand for venture debt remains strong for companies that aim to preserve control, stay autonomous, and maintain flexibility over capital structure Hosted by DealFlow Events, The Venture Debt Conference on March 6, 2024, in New York City features 30+ experts, interactive panel discussions, and opportunities to meet with the largest group of dealmakers in the lending business Emerging venture debt lenders bring expertise to startups and new companies navigating complex financial arrangements Attendance is free for qualified C-level executives representing a venture-backed or…

WednesdayFeb 28, 2024 9:00 am

Diamond Lake Minerals Inc. (DLMI) Continues Building Digital Asset Exchange Strategy with Investment in Avrio Trading Engine

Utah-based Diamond Lake Minerals is establishing its reputation as an innovator in digital assets and government-regulated security tokens through strategic partnerships and investments that strengthen its vertically integrated offerings DLMI’s suite of industry-agnostic subsidiaries serves as a gateway to digital asset investment by imbuing those subsidiaries with registered security token offerings that shareholders accustomed to real world assets can use to dip a toe into the emerging digital market DLMI recently invested in registered market infrastructure provider Avrio Worldwide, PBC, to provide itself with the trading engine technology necessary to “capture and scale market opportunities” in accordance with best practices…

TuesdayFeb 27, 2024 3:30 pm

QualityStocksNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) CNM-Au8 Aiming to Address Neurodegenerative Diseases from a New Angle

Clene (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), Parkinson’s and multiple sclerosis (“MS”). “The company’s lead drug candidate is CNM-Au8, an innovative nanomedicine uniting the principles of physics, chemistry, materials science, and biology to address neurodegenerative diseases from a new angle. Clene uses catalytic boosting of energy metabolism to enable dying neurons to resist the multiple stressors associated with disease, allowing them not only to survive but also to function,” a recent article reads. The article discusses CNM-Au8 development pathways, which…

TuesdayFeb 27, 2024 2:45 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Uniquely Positioned to Capitalize on Increasing Demand for Electronic Monitoring Solutions

SuperCom Ltd. (NASDAQ: SPCB), a provider of secured solutions for e-Government, IoT and cybersecurity sectors, aims to revolutionize public safety worldwide through proprietary electronic monitoring technology, data intelligence and complementary services. “SuperCom’s proprietary PureSecurity suite is an all-in-one, field-proven offender monitoring system, with services such as GPS monitoring, home detention, domestic violence prevention, and more. The suite is specifically tailored to meet each client’s needs. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new capabilities, such as amplified data analysis, predictive modeling and streamlined automation – geared toward optimizing decision making and operational efficiency… SuperCom’s PureSecurity suite…

TuesdayFeb 27, 2024 12:49 pm

QualityStocksNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Featured as ‘Beacon of Innovation’ in Corporate Investment Times

Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company that specializes in the development and support of digital assets and SEC-registered security tokens, was featured in the most recent edition of the Corporate Investment Times. The article, titled “Pioneering the Future of Digital Assets and Security Tokens,” discusses a profound transformation in the financial world driven by the emergence of tokenization. In this new realm, “visionaries such as Larry Fink of BlackRock and Jonathan Larsen of Ping A Global Voyager Fund foresee a future where digital assets traded on innovative protocols revolutionize transactions… where settlements occur instantaneously, and fees plummet,…

TuesdayFeb 27, 2024 12:15 pm

QualityStocksNewsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Fr8App to Help Manage Transportation Needs for Envases Universales

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company whose custom-developed, industry leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, today announced a significant collaboration with Envases Universales, one of the largest packaging companies worldwide. According to the announcement, Fr8App was awarded key routes through Envases’ annual 2024 RFQ, underscoring its commitment to delivering exceptional transportation services and its capability to meet the evolving needs of its clients. “We are thrilled to have been chosen by Envases Universales to help manage their transportation needs over the coming year,” said Fr8App’s CEO…

TuesdayFeb 27, 2024 12:00 pm

Astiva Health Inc. Championing Culturally Sensitive Healthcare for Aging Asian American Population

By 2060, the older Asian population in the U.S. is expected to reach 8.5 million, making up 9% of the country's elderly demographic, signaling a significant increase from 4% in 2014 Astiva Health is leading the charge in creating essential healthcare solutions tailored for this expanding demographic, demonstrating a deep understanding of their unique healthcare needs Astiva Health has introduced groundbreaking programs, including language-specific healthcare services and wellness initiatives, specifically designed for the diverse aging Asian American community Astiva Health is working serve the Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the…

TuesdayFeb 27, 2024 11:57 am

QualityStocksNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Inks Deal with TráTek Monitoring Services, Expands Services in Canada

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, is partnering with TráTek Monitoring Services to expand its footprint in Canada. The company announced that TráTek, which is based in British Columbia, has signed an agreement to adopt its SOBRsafe technology for use in its family law practice with voluntary pretrial clients. In conjunction with the agreement, TráTek has purchased multiple SOBRcheck(TM) and SOBRsure(TM) devices. TráTek has become a licensed channel partner of alcohol monitoring technologies and works to support the legal system across Canada. According to the announcement, the company plans to deploy SOBRsafe solutions nationwide through its regional…

TuesdayFeb 27, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

Astrotech reported financial results for the quarter ended December 31, 2023, recording year-to-date revenue of $1,540,000 The company attributed the growth to the successful fulfillment of two significant purchase orders for the TRACER 1000(TM), the world’s first mass spectrometer-based explosive trace detectors (“ETD”), to customers in Romania Astrotech is focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries 1st Detect Corp., AgLAB Inc., Pro-Control Inc., and BreathTech Corp. The company and its subsidiaries are positioned to capitalize on burgeoning markets, including the global mass spectrometry market, expected to grow from an estimated $6.77 billion in…

TuesdayFeb 27, 2024 10:30 am

Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023

Sigyn's common stock, temporarily trading under the ticker symbol "SIGYD", is set to revert back to its historic symbol "SIGY" on February 29, 2024. The company, as part of its 2023 Year-End Report, summarized its development of medical technologies that target to overcome clearly defined limitations in global health. During 2023, Sigyn expanded its line-up of medical technologies designed to enhance the benefit of cancer therapies. The company’s cancer treatment pipeline now includes ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM). The company believes the successful clinical advancement of Sigyn Therapy(TM) to treat pathogen-associated conditions beyond the reach of drugs, may offer a…

Site Search

Company Search